Clinical Trial Update: Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral panobinostat (LBH589) for efficacy and safety in adults with advanced soft tissue sarcoma after prior treatment, with completed st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• LBH589 (panobinostat)

Snippet

Sponsor: Centre Leon Berard | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED